Amos Lais Financial has filed documents with the U.S. Securities and Exchange Commission announcing the public offering of two series of senior unsecured notes.

老虎证券2026/06/04 13:23

Show original

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage

Eli Lilly stated on Monday that its oral weight-loss drug, Foundayo, has captured over 30% of the market share among new patients in the US oral obesity treatment market, narrowing the early lead achieved by Danish competitor Novo Nordisk with its Wegovy oral tablets.

智通财经•2026/09/15 03:21

2-Yr Benchmark Govt Yields - Germany vs Other Nations

Dow Jones•2026/09/15 03:10

2-Yr Benchmark Govt Yields - U.S. vs Other Nations

Dow Jones•2026/09/15 03:10

10-Yr Benchmark Govt Yields - U.S. vs Other Nations

Dow Jones•2026/09/15 03:10